Other languages Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 21/06/2024 am IST			5-day change	1st Jan Change
57.61 ^CNY	-0.26%		-0.96%	+10.05%

22/04	Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/03	China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6%	MT

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
China Stocks Advance Over Positive Economic Data; Amoytop Biotech Rises 6%	18/03
Amoytop Biotech's 2023 Profit Jumps 93%	26/02
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
'Hawkish' China military squeeze on Taiwan likely after election	03/01
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	19/23/19
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/23/17
Sector Update: Health Care Stocks Edge Higher Premarket Monday	15/23/15
Top Premarket Gainers	15/23/15
Aligos Therapeutics to Collaborate with Xiamen Amoytop Biotech on Liver Disease Treatments; Aligos Shares Jump	15/23/15
Aligos Therapeutics Announces Research Collaboration and Development Agreement with Xiamen Amoytop Biotech Co. Ltd. for Use of Aligos' Oligonucleotide Platform for the Treatment of Liver Diseases	13/23/13
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/22/25
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	18/22/18
Guangzhou Houbao Investment Partnership Enterprise (Limited Partnership) completed the acquisition of a 5.04% stake in Xiamen Amoytop Biotech Co., Ltd. from Tonghua Dongbao Pharmaceutical Co., Ltd..	19/22/19
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25
Qingdao Dingxing Qiguang Medical Industry Investment Fund Partnership (Limited Partnership), managed by Guojin Dingxing Investment Co., Ltd. completed the acquisition of 5.0025% stake in Xiamen Amoytop Biotech Co., Ltd. (SHSE : 688278) from Tonghua Dongbao Pharmaceutical Co., Ltd..	27/22/27
Xiamen Amoytop Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/21/27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Xiamen Amoytop Biotech Co., Ltd.

Equities

688278

CNE100003RT3

Other languages

Filters